• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度慢性心力衰竭患者中高剂量经皮硝酸甘油治疗反应者对血流动力学效应的早期耐受性

Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.

作者信息

Roth A, Kulick D, Freidenberger L, Hong R, Rahimtoola S H, Elkayam U

出版信息

J Am Coll Cardiol. 1987 Apr;9(4):858-64. doi: 10.1016/s0735-1097(87)80242-5.

DOI:10.1016/s0735-1097(87)80242-5
PMID:3104435
Abstract

Transdermal systems for delivery of nitroglycerin have been shown to provide sustained blood levels of the drug for at least 24 hours. Investigations of hemodynamic effects of transdermal nitroglycerin in patients with heart failure have demonstrated a transient reduction in pressure lasting less than the expected 24 hours. These findings could be due to the development of circulatory tolerance to the vasodilatory effects of nitroglycerin or to insufficient drug dosing. In the present study, we compared the hemodynamic effects of the first and the second doses of high dose (120 mg) transdermal nitroglycerin given 24 hours apart in 11 responders (greater than or equal to 20% reduction in mean pulmonary artery wedge pressure lasting greater than or equal to 2 hours). Initiation of nitroglycerin therapy resulted in a significant reduction in mean right atrial pressure lasting for 14 hours and in a reduction in mean pulmonary artery and mean pulmonary artery wedge pressures lasting 24 hours. After administration of the second dose, mean right atrial pressure at 2 hours (9 +/- 5 versus 7 +/- 4 mm Hg), 4 hours (8 +/- 5 versus 6 +/- 4 mm Hg) and 8 hours (8 +/- 5 versus 6 +/- 3 mm Hg) was higher than after the first dose (p less than 0.05). Both mean pulmonary artery and mean pulmonary artery wedge pressures were significantly higher after the second nitroglycerin dose.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

经皮给药的硝酸甘油系统已被证明可使药物血药浓度持续至少24小时。对心力衰竭患者经皮应用硝酸甘油的血流动力学效应研究表明,压力短暂降低,持续时间短于预期的24小时。这些结果可能是由于对硝酸甘油血管舒张作用产生了循环耐受性,或者是药物剂量不足。在本研究中,我们比较了11例有反应者(平均肺动脉楔压降低大于或等于20%,持续大于或等于2小时)在间隔24小时给予两剂高剂量(120 mg)经皮硝酸甘油后的血流动力学效应。开始硝酸甘油治疗后,平均右心房压力显著降低,持续14小时,平均肺动脉压和平均肺动脉楔压降低,持续24小时。给予第二剂后,2小时(9±5对7±4 mmHg)、4小时(8±5对6±4 mmHg)和8小时(8±5对6±3 mmHg)的平均右心房压力高于第一剂后(p<0.05)。第二次给予硝酸甘油后,平均肺动脉压和平均肺动脉楔压均显著升高。(摘要截短于250字)

相似文献

1
Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.重度慢性心力衰竭患者中高剂量经皮硝酸甘油治疗反应者对血流动力学效应的早期耐受性
J Am Coll Cardiol. 1987 Apr;9(4):858-64. doi: 10.1016/s0735-1097(87)80242-5.
2
[The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].[经皮硝酸甘油对充血性心力衰竭患者的急性、治疗后慢性持续及慢性间歇性(治疗窗为4和6小时)血流动力学效应]
Cardiologia. 1991 Jun;36(6):451-60.
3
Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.大剂量经皮硝酸甘油对慢性充血性心力衰竭患者的血流动力学及激素影响
Am J Cardiol. 1985 Sep 15;56(8):555-9. doi: 10.1016/0002-9149(85)91184-1.
4
Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.与安慰剂相比,透皮硝酸甘油对充血性心力衰竭患者的剂量需求及血流动力学影响。
Circulation. 1985 May;71(5):980-6. doi: 10.1161/01.cir.71.5.980.
5
Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.在慢性心力衰竭患者中联合使用肼屈嗪预防对硝酸盐血流动力学效应的耐受性。
J Am Coll Cardiol. 1995 Dec;26(7):1575-80. doi: 10.1016/0735-1097(95)00368-1.
6
Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.间歇性经皮给予硝酸甘油对慢性充血性心力衰竭的血流动力学影响
Am J Cardiol. 1987 Apr 1;59(8):895-9. doi: 10.1016/0002-9149(87)91115-5.
7
Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure.充血性心力衰竭患者对透皮硝酸甘油迅速产生耐受性。
Ann Intern Med. 1986 Mar;104(3):295-8. doi: 10.7326/0003-4819-104-3-295.
8
Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.充血性心力衰竭患者经皮硝酸甘油的药代动力学-血流动力学研究
J Am Coll Cardiol. 1987 Feb;9(2):420-5. doi: 10.1016/s0735-1097(87)80398-4.
9
Sustained beneficial hemodynamic effects of low transdermal nitroglycerin doses compared with placebo in patients with congestive heart failure.与安慰剂相比,低剂量经皮硝酸甘油对充血性心力衰竭患者具有持续有益的血流动力学效应。
Clin Cardiol. 1988 Feb;11(2):79-85. doi: 10.1002/clc.4960110206.
10
[Hemodynamic effect and duration of action of Deponit 10 in patients with congestive heart insufficiency].[Deponit 10对充血性心力衰竭患者的血流动力学效应及作用持续时间]
Z Kardiol. 1986;75 Suppl 3:86-9.

引用本文的文献

1
Role of superoxide dismutase in in vivo and in vitro nitrate tolerance.超氧化物歧化酶在体内和体外硝酸盐耐受性中的作用。
Br J Pharmacol. 1999 Jul;127(5):1224-30. doi: 10.1038/sj.bjp.0702622.
2
The physiology and pathophysiology of the nitric oxide/superoxide system.一氧化氮/超氧化物系统的生理学与病理生理学
Herz. 1997 Jun;22(3):158-72. doi: 10.1007/BF03044353.
3
Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin.
Eur J Clin Pharmacol. 1993;44(1):47-50. doi: 10.1007/BF00315279.
4
Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.充血性心力衰竭中不使用血管紧张素转换酶抑制剂的血管扩张剂治疗——效用与局限性
Cardiovasc Drugs Ther. 1989 Jun;3(3):375-96. doi: 10.1007/BF01858109.
5
Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.经皮硝酸甘油(三硝酸甘油酯)。其药理学与治疗用途综述。
Drugs. 1990 Dec;40(6):880-902. doi: 10.2165/00003495-199040060-00009.
6
Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.硝酸盐类药物:如今为何以及应如何使用?硝酸甘油、硝酸异山梨酯和5-单硝酸异山梨酯临床应用价值的现状。
Eur J Clin Pharmacol. 1990;38 Suppl 1:S35-51. doi: 10.1007/BF01417564.
7
Duration and reproducibility of initial hemodynamic effects of flosequinan in patients with congestive heart failure.氟司喹南对充血性心力衰竭患者初始血流动力学效应的持续时间及可重复性。
Cardiovasc Drugs Ther. 1990 Jun;4(3):705-12. doi: 10.1007/BF01856558.